More News

24 Apr 2007 Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment
24 Apr 2007 Synosia Therapeutics Announces Second Major Pharmaceutical Deal
24 Apr 2007 KaloBios Licenses Humaneering(TM) Technology to Major Pharmaceutical Company
24 Apr 2007 Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
24 Apr 2007 Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
24 Apr 2007 Prasco Enters into Agreement with sanofi-aventis to Market the Authorized Generic Versions of Ambien(R) (Zolpidem Tartrate) CIV
24 Apr 2007 Vectura Announces Successful Outcome of Second Phase IIb Clinical Study on Inhaled Erectile Dysfunction Product
23 Apr 2007 AstraZeneca to Acquire MedImmune For $58 Per Share in a Fully Recommended, All-cash Transaction with a Total Enterprise Value of $15.2 Billion
21 Apr 2007 FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
21 Apr 2007 Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
20 Apr 2007 Novacea Acquires Worldwide Development and Commercialization Rights for Its Oncology Candidate AQ4N
20 Apr 2007 Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
20 Apr 2007 Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
19 Apr 2007 Completion of Phase I Trial on the Anti-influenza Drug CS-8958
19 Apr 2007 Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
19 Apr 2007 Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
19 Apr 2007 Viragen Announces European Multiferon(R) Licensing Agreement
18 Apr 2007 DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
18 Apr 2007 Wockhardt to soon introduce Kelocote to treat scars
18 Apr 2007 Wockhardt to soon introduce Kelocote to treat scars
18 Apr 2007 Prevascar Phase II Results
18 Apr 2007 Salix Pharmaceuticals Licenses DIACOL(TM) To Dr. Falk Pharma in Europe
17 Apr 2007 Cambridge Antibody Technology and Philochem Announce Technology Evaluation Agreement
17 Apr 2007 Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
17 Apr 2007 Regulatory Review Allows LCT Diabetes Clinical Program to Proceed

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top